Abgenix Inc. , Chugai Pharmaceutical Company Ltd. align in antibody therapies.(Brief Article)

Abgenix Inc. entered a multiyear collaboration with Chugai Pharmaceutical Co. Ltd. to develop fully human monoclonal antibody therapies, while Tokyo based Chugai separately gained rights to develop products based on patents belonging to Abgenix. Specific financial terms of the development agreement were not disclosed, but Fremont, Calif.-based …